Gastroenterology expert column - IBD and pregnancy

MedGenMed Medscape General Medicine

Volumn 6, Issue 4, 2004, Pages

  Calderwood, Audrey H ^a   Kane, Sunanda V ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZATHIOPRINE; BETAMETHASONE; BUDESONIDE; CEPHALOSPORIN DERIVATIVE; CYCLOSPORIN; DEXAMETHASONE; DIPHENOXYLATE; ERYTHROMYCIN; FOLIC ACID; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALAZOSULFAPYRIDINE;

ARTICLE; BLOOD PLACENTA BARRIER; BREAST FEEDING; CROHN DISEASE; DIARRHEA; DISEASE CLASSIFICATION; DRUG PENETRATION; ENTERITIS; FEMALE; FEMALE FERTILITY; FOLIC ACID DEFICIENCY; HUMAN; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; PREGNANCY; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TERATOGENICITY; ULCERATIVE COLITIS;

EID: 25144432850     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Banks B, Korelitz BI, Zetzel L. The course of non-specific ulcerative colitis: A review of twenty years of experience and late results. Gastroenterology. 1957;32:983-1012.
2. Woolfson K, Cohen Z, McLeod RS. Crohn's disease and pregnancy. Dis Colon Rectum. 1990;33:869-873.
3. Korelitz BI. Inflammatory bowel disease and pregnancy. In Pregnancy and Gastro-intestinal disorders. Gastroenterol Clin North Am. 1998;27:213-224.
4. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology. 1990;9:987-994.
5. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: A case control study by European collaborative group. Gut. 1986;27:821-825.
6. Yang H, McElree C, Roth MP, et al. Familial empirical risks for inflammatory bowel disease: Differences between Jews and non-Jews. Gut. 1993;34:517-524.
7. Arkuran C, McComb P. Crohn's disease and tubal infertility: The effect of adhesion formation. Clin Exp Obstet Gynecol. 2000;27:12-13.
8. Olsen KO, Berndtsson I, Oresland T, et al. Ulcerative colitis: Female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology. 2002;122:15-19.
9. Tiainen J, Matikainen M, Hiltunen KM. Ileal J-pouch-anal anastomosis, sexual dysfunction, and fertility. Scand J Gastroenterol. 1999;34:185-188.
10. Wikland M, Jansson I, Asztely M, et al. Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy. Int J Colorectal Dis. 1990;5:49-52.
11. Johnson P, Richard C, Ravid A, et al. Female fertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2004;47:1119-1126.
12. Birnie GG, McLeod TI, Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut. 1981;22:452-455.
13. Levi AJ, Fisher AM, Hughes L, et al. Male infertility due to sulphasalazine. Lancet. 1979;2:276-278.
14. O'Morain C, Smethurst, P, Dore CHG, et al. Reversible male infertility due to sulphasalazine: Studies in man and rat. Gut. 1984;25:1078-1084.
15. Toth A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril. 1979;31:538-540.
16. Mogadam M, Dobbins WO, Korelitz BI, et al. Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology. 1981;80:72-76.
17. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - A population-based cohort study. Am J Obstet Gynecol. 1997;177:942-946.
18. Fonager K, Sorensen HT, Olsen J, et al. Pregnancy outcome for women with Crohn's disease: A follow-up study based on linkage between national registries. Am J Gastroenterol. 1998;93:2426-2430.
19. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: A population-based cohort study. Am J Gastroenterol. 2002;97:641-648.
20. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut. 1984;25:52-56.
21. Morales M, Berney T, Jenny A, et al. Crohn s disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology. 2000;47:1595-1598.
22. Nielsen OH, Andreasson B, Bondensen S, et al. Pregnancy in Crohn's disease. Scand J Gastroenterol. 1984;19:724-732.
23. Nielsen OH, Andreasson B, Bondensen S, et al. Pregnancy in ulcerative colitis. Scand J Gastroenterol. 1983;18:735-742.
24. Rogers RG, Katz VL. Course of Crohn's disease during pregnancy and its effect on pregnancy outcome: A retrospective review. Am J Perinatol. 1995;12:262-264.
25. Bortoli A, Tartarella M, Prada A, et al. Inflammatory bowel disease and pregnancy. Gastroenterology. 1997;112:A940.
26. Marteau P, Tennenbaum R, Elefant E, et al. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther. 1998;12:1101-1108.
27. Porter RJ, Stirrat GM. The effects of inflammatory bowel disease on pregnancy: A case-controlled retrospective analysis. Br J Obstet Gynaecol. 1986;93:1124-1131.
28. Nwokolo C, Tan WC, Andrews HA, et al. Surgical resections in parous patients with distal ileal and colonic Crohn's disease. Gut. 1994;35:220-223.
29. Castiglione F, Pignata S, Morace F, et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol. 1996;28:199-204.
30. Kane SV, Hanauer SB, Kiesel J, et al. HLA disparity determines disease activity through pregnancy in women with IBD. Am J Gastroenterol. 2004;99:1523-1526.
31. Shoenut JP, Semelka RC, Silverman R, et al. MRI in the diagnosis of Crohn's disease in two pregnant women. J Clin Gastroenterol. 1993;17:244-247.
32. Brent RL. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: Counseling the pregnant and nonpregnant patient about these risks. Semin Oncol. 1989;16:347-368.
33. Cappell MS, Sidhom O. Multicenter, multiyear study of safety and efficacy of flexible sigmoidoscopy during pregnancy in 24 females with follow-up of fetal outcome. Dig Dis Sci. 1995;40:472-479.
34. Cappell MS, Colon VJ, Sidhom OA. A stuffy of 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dig Sci. 1996;41:2353-2361.
35. Roubenoff R, Hoyt J, Petri M, et al. Effects of anti-inflammatory and immunosuppressive drugs on pregnancy and fertility. Semin Arthr Rheum. 1988;18:88-110.
36. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;338:1128-1137.
37. Ambrosius Christensen LA, Rasmussen SN, Honore Hansen S, Bondesen S, Hvidberg EF. Salazosulfapyridine and metabolites in fetal and maternal body fluids with special reference to 5-aminosalicylic acid. Acta Obstet Gynecol Scand. 1987;66:433-435.
38. Trallori G, d'Albasio G, Bardazzi G, et al. 5-Aminosalicylic acid in pregnancy: Clinical report. Ital J Gastroenterol. 1994;26:75-78.
39. Habal FM, Hui G, Greenberg GR. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: Safety and clinical course. Gastroenterology. 1993;105:1057-1060.
40. Diav-Citrin O, Park YH, Veerasuntharam G, et al. The safety of mesalamine in human pregnancy: A prospective controlled cohort study. Gastroenterology. 1998;114:23-28.
41. Diav-Citrin O, Shechtman S, Gotteiner T, et al. Pregnancy outcome after gestational exposure to metronidazole: A prospective controlled cohort study. Teratology. 2001;63:186-192.
42. Berkovitch M, Pastuszak A, Gazarian M, et al. Safety of the new quinolones in pregnancy. Obstet Gynecol. 1994;84:535-538.
43. Alstead EM, Ritchie JK, Lennard-Jones JE, et al. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology. 1990;99:443-446.
44. Francella A, Dayan A, Bodian C, et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease : a retrospective cohort study. 2003;124:9-17.
45. Present D, Meltzer S, Krumholz M, et al. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity. Ann Intern Med. 1989;111:641-649.
46. Rajapakse RO, Korelitz BI, Zlatanic J, et al. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol. 2000;95:684-688.
47. Einarson A, Mastroiacovo P, Arnon J, et al. Prospective, controlled, multicentre study of loperamide in pregnancy. Can J Gastroenterol. 2000;14:185-187.
48. Baron TH, Ramirez B, Richter JE. Gastrointestinal motility disorders during pregnancy. Ann Intern Med. 1993;118:366-375.
49. Van Horn C and Barrett P. Pregnancy, delivery and postpartum experiences of fifty-four women with ostomies. J Wound Ostomy Continence Nurs. 1997;24:151-162.